✦ LIBER ✦

Mechanisms of resistance to EGFR inhibitors in head and neck cancer

✍ Scribed by Jonathan B. Cooper; Ezra Eddy Wyssam Cohen

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 209 KB
Volume: 31
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21109

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositol‐3‐kinase/v‐AKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression in head and neck squamous cell carcinoma (HNSCC), the majority of patients do not respond to EGFR inhibitors. This review focuses on mechanisms of resistance to these agents in HNSCC, and how these may be unique when compared with other malignancies such as non‐small cell lung and colorectal cancers. Published studies and abstracts reveal that there are likely several mechanisms underlying resistance, suggesting that different strategies will be required to improve efficacy of EGFR inhibitors in HNSCC. © 2009 Wiley Periodicals, Inc. Head Neck, 2009

📜 SIMILAR VOLUMES

TGF-α and EGFR in head and neck cancer

✍ Jennifer R. Grandis; David J. Tweardy 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

The upper aerodigestive tract mucosa of patients who develop squamous cell carcinoma of the head and neck (SCCHN) is predisposed to abnormally regulated growth, evidenced by the high incidence of synchronous and metachronous malignancies. We conducted a series of experiments to show that aberrant re

Mechanisms of hypercalcemia in patients

Mechanisms of hypercalcemia in patients with head and neck cancer

✍ Angel, Michael F. ;Stewart, Andrew ;Pensak, Myles L. ;Pillsbury, Harold R. C. ;S 📂 Article 📅 1982 🏛 Wiley (John Wiley & Sons) ⚖ 491 KB 👁 2 views

## Abstract Hypercalcemia associated with head and neck malignancy is not an uncommon occurrence; its causes are multiple. Eight hypercalcemic patients with head and neck malignancy were studied. Serum calcium, serum phosphorus, tubular phosphorus threshold, fasting calcium excretion, plasma 1,25‐d

Sequence dependence of cell growth inhib

Sequence dependence of cell growth inhibition by EGFR–tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer

✍ Carmen M. Klass; Mi Sun Choe; Selwyn J. Hurwitz; Mourad Tighiouart; Xin Zhang; Z 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

## Abstract ## Background This study was to explore whether the efficacy of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (Z, Iressa, gefitinib) plus chemotherapeutic agents docetaxel (D) and cisplatin (P) may benefit from sequencing of the combination. ## Methods

Dynamic survivin in head and neck cancer

Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potential

✍ Burkhard M. Lippert; Shirley K. Knauer; Verena Fetz; Wolf Mann; Roland H. Staube 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 594 KB

## Abstract Although disease management of head and neck squamous cell carcinomas (HNSCC) has improved significantly, therapy resistance leading to tumor recurrence still counteracts improvement of long‐term survival. Consequently, identification of molecular markers that signal increased risk of t

Mechanisms and modulation of resistance

Mechanisms and modulation of resistance to chemotherapy in ovarian cancer

✍ Raymond P. Perez; Thomas C. Hamilton; Robert F. Ozols; Robert C. Young 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1005 KB

Chemotherapy for advanced ovarian cancer remains suboptimal. Despite the improvements in objective response rates realized with cisplatin-based combination chemotherapeutic regimens, most patients still die of refractory cancer. Drug resistance has emerged as the single most important determinant of

Applications of brachytherapy in head an

Applications of brachytherapy in head and neck cancer

✍ Louis B. Harrison 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 2 views

Brachytherapy offers the radiation oncologist the opportunity to deliver high doses of radiation to the tumor, with minimal doses to the surrounding normal tissue. This combination enhances the therapeutic ratio. It allows for enhanced tumor control, with minimal toxicity. When utilized, it often al